Panelists discuss how data from MDA 2025 demonstrate that delandistrogene moxeparvovec (gene therapy for DMD) shows statistically significant improvements in motor function outcomes including North ...
This Research Topic is Volume II of a series. The previous volume, which has attracted over 21k views can be found here:Transforming Chronic Disease ...
The last time I wrote an article on Alector, Inc. (ALEC), I analyzed its enormous potential in using its TREM2 receptor drug AL002 being studied in the phase 2 INVOKE-2 trial, which was targeting ...
From Tom Insel’s perspective, the future of psychiatry had never looked so bright. It was May 2015, and Insel, then the director of the National Institute of Mental Health, the world’s largest and ...
Biohaven Ltd. reported positive results from a pivotal study using troriluzole for the treatment of patients with spinocerebellar ataxia; the Drug achieved 50% to 70% of slowing of disease progression ...
Traws Pharma, Inc. announced promising results for ratutrelvir, a main protease inhibitor for COVID-19, suggesting it can be administered without ritonavir, potentially reducing the risk of drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback